Medicine Man Technologies (NEOE:SHWZ) ROCE % : -2.30% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Medicine Man Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medicine Man Technologies's annualized ROCE % for the quarter that ended in Jun. 2024 was -2.30%.

Medicine Man Technologies ROCE % Historical Data

The historical data trend for Medicine Man Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies ROCE % Chart

Medicine Man Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-61.11

-47.30

17.39

10.60

5.93

Medicine Man Technologies Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial															8.44	16.97	-21.43	-5.33	-2.30

Medicine Man Technologies ROCE % Calculation

Medicine Man Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	23.156	/	( ( (438.637 - 64.367)	+	(480.486 - 74.401) )	/ 2 )
	=	23.156	/	( (374.27	+	406.085)	/ 2 )
	=	23.156	/	390.1775
	=	5.93 %

Medicine Man Technologies's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-8.112	/	( ( (469.167 - 110.821)	+	(465.437 - 116.909) )	/ 2 )
	=	-8.112	/	( ( 358.346	+	348.528 )	/ 2 )
	=	-8.112	/	353.437
	=	-2.30 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

Medicine Man Technologies (NEOE:SHWZ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medicine Man Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicine Man Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicine Man Technologies Inc (NEOE:SHWZ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SHWZ:USA

Address

865 N. Albion Street, Suite 300, Denver, CO, USA, 80220

Website

https://www.schwazze.com

Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.